Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Agenus Inc.

Agenus to Participate in February Investor Conferences
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology Conference
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus Provides Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN VBIV
Agenus to Host “The Road Taken” R&D Event on November 12, 2022
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report
From Agenus Inc.
Via Globe NewsWire
Tickers AGEN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.